Changes of inflammatory factors after intravitreal triamcinolone acetonide for macular edema with central retinal vein occlusion

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 3, 2013, Pages 363-365

  Noma, Hidetaka ^a   Funatsu, Hideharu ^a   Mimura, Tatsuya ^b  

^a Tokyo Women s Medical University   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; PIGMENT EPITHELIUM DERIVED FACTOR; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN;

AGED; AQUEOUS HUMOR; ARTICLE; CASE REPORT; CENTRAL MACULAR THICKNESS; CENTRAL RETINA VEIN OCCLUSION; DRUG EFFICACY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RETINA MACULA EDEMA; VISUAL ACUITY;

AGED; AQUEOUS HUMOR; EYE PROTEINS; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; NERVE GROWTH FACTORS; RETINAL VEIN OCCLUSION; SERPINS; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876785964     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0222     Document Type: Article

References (10)

1. Noma, H., Funatsu, H., Mimura, T., Harino, S., and Hori, S. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology. 116:87-93, 2009.
2. Noma, H., Funatsu, H., Harino, S., Mimura, T., Eguchi, S., and Hori, S. Vitreous inflammatory factors in macular edema with central retinal vein occlusion. Jpn. J. Ophthalmol. 55:248-255, 2011.
3. Yoshimura, T., Sonoda, K.H., Sugahara, M., et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One. 4:e8158, 2009.
4. Ip, M.S., Scott, I.U., VanVeldhuisen, P.C., et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch. Ophthalmol. 127:1101-1114, 2009.
5. Noma, H., Funatsu, H., Mimura, T., Eguchi, S., Shimada, K., and Hori, S. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Curr. Eye Res. 36:256-263, 2011.
6. Wang, K., Wang, Y., Gao, L., Li, X., Li, M., and Guo, J. Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression. Biol. Pharm. Bull. 31:1541-1546, 2008.
7. Tombran-Tink, J., Lara, N., Apricio, S.E., et al. Retinoic acid and dexamethasone regulate the expression of PEDF in retinal and endothelial cells. Exp. Eye Res. 78:945-955, 2004. (Pubitemid 38402203)
8. Park, S.P., and Ahn, J.K. Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion. Clin. Experiment. Ophthalmol. 37:490-495, 2009.
9. Park, S.P., and Ahn, J.K. Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion. Clin. Experiment. Ophthalmol. 36:831-835, 2008.
10. Brown, D.M., Campochiaro, P.A., Singh, R.P., et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 117:1124-1133, e1, 2010.